Tag: Ribociclib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Ribociclib

Ribociclib Sales Size 2021 by Product, Revenue, Price, Industry Share, Growth Opportunity and ...

Added to Collection on: 2021-07-26 07:07:30

Tags for this article:

Chemical compounds
Marketing strategy
Protein kinase inhibitors
Cyclopentanes
Piperazines
Competition
Market share
Novartis
Ribociclib
Pricing

Click the tags to see associated articles and topics

View Article Details
Novartis presents new Kisqali® data showing longest median overall survival ever reported ...

Added to Collection on: 2021-09-19 11:26:15

Tags for this article:

Chemical compounds
Protein kinase inhibitors
Piperazines
Cyclopentanes
Pyridines
Pyrimidines
Ribociclib
Palbociclib
Breast cancer
Astex Pharmaceuticals
Letrozole
Fulvestrant
Novartis AG
Gabriel N. Hortobagyi

Click the tags to see associated articles and topics

View Article Details
Novartis, determined to dethrone Pfizer, will launch bold Kisqali-Ibrance head-to-head trial ...

Added to Collection on: 2021-09-19 15:00:00

Tags for this article:

Chemical compounds
Organic compounds
Protein kinase inhibitors
Piperazines
Cyclopentanes
Breakthrough therapy
Pyridines
Palbociclib
Ribociclib
Triple-negative breast cancer
Cyclin-dependent kinase 4
Abemaciclib
Novartis
Ibrance

Click the tags to see associated articles and topics

View Article Details
SABCS Studies Show Promise of ctDNA Analysis in Individualizing CDK4/6 Inhibitor ...

Added to Collection on: 2021-12-11 14:39:05

Tags for this article:

Chemical compounds
Clinical medicine
Organic compounds
Protein kinase inhibitors
Piperazines
Cyclopentanes
Antiestrogens
Breakthrough therapy
Palbociclib
Ribociclib
Selective estrogen receptor degrader
Fulvestrant
Giampaolo Bianchini
François-Clément Bidard
Minetta Liu
Letrozole

Click the tags to see associated articles and topics

View Article Details
AstraZeneca's Enhertu demonstrates 'statistically significant' survival rates in ... - Sharecast.com

Added to Collection on: 2022-02-21 07:18:55

Tags for this article:

Chemical compounds
Organic compounds
Cancer
Protein kinase inhibitors
Breast cancer
Piperazines
HER2/neu
Metastatic breast cancer
Trastuzumab emtansine
Ribociclib
AstraZeneca
Daiichi Sankyo

Click the tags to see associated articles and topics

View Article Details
Kisqali increases overall survival in advanced breast cancer patients by 12 months

Added to Collection on: 2022-03-10 13:18:47

Tags for this article:

Chemical compounds
Protein kinase inhibitors
Piperazines
Cyclopentanes
Pyridines
Pyrimidines
Ribociclib
Letrozole
Breast cancer
HER2/neu
CDK inhibitor
Palbociclib

Click the tags to see associated articles and topics

View Article Details
New CDK4/6i data at ASCO reinforce Novartis Kisqali® as only drug in class with ...

Added to Collection on: 2022-06-03 16:23:40

Tags for this article:

Chemical compounds
Organic compounds
Protein kinase inhibitors
Piperazines
Cyclopentanes
Pyridines
Breakthrough therapy
Ribociclib
Palbociclib
Breast cancer
Astex Pharmaceuticals
Abemaciclib
Letrozole
Novartis AG

Click the tags to see associated articles and topics

View Article Details
Survival Data for Palbociclib in ER+HER2– Advanced Breast Cancer Reported From ...

Added to Collection on: 2022-06-05 18:03:57

Tags for this article:

Chemical compounds
Organic compounds
Protein kinase inhibitors
Piperazines
Cyclopentanes
Aminopyridines
Breakthrough therapy
Palbociclib
Letrozole
Breast cancer
Ribociclib
Kathleen I. Pritchard

Click the tags to see associated articles and topics

View Article Details
Hope S. Rugo, MD, on Comparing CDK4/6 Inhibitors in HR+/HER2– Advanced Breast Cancer

Added to Collection on: 2022-07-24 14:03:55

Tags for this article:

Chemical compounds
Protein kinase inhibitors
Piperazines
Pyridines
Cyclopentanes
Breakthrough therapy
Ribociclib
Abemaciclib
Breast cancer
Hope Rugo
Aromatase inhibitor
American Society of Clinical Oncology

Click the tags to see associated articles and topics

View Article Details
Lilly's Verzenio Extends Five-Year Breast Cancer Survival, Adds to Debate Over Best CDK4 ...

Added to Collection on: 2022-09-11 00:27:34

Tags for this article:

Chemical compounds
Organic compounds
Protein kinase inhibitors
Piperazines
Cyclopentanes
Breakthrough therapy
Pyridines
Palbociclib
Ribociclib
CDK inhibitor
Abemaciclib
Letrozole

Click the tags to see associated articles and topics

View Article Details